Sunshine Biopharma Inc. -27SBFMWPreferred / convertible
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$0.07avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Sunshine Biopharma Inc. -27 (SBFMW) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was UBS Group AG ($2K).
- Company
- Sunshine Biopharma Inc. -27
- CUSIP
- 867781502
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,396 shares bought, net +1,396 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| UBS Group AG | — | Add +6.2% | 23,879 | $2K |
"% of holder's portfolio" is SBFMW's weight in each manager's 13F, not the share of Sunshine Biopharma Inc. -27 the manager owns.